A ubiquitination factor, NosA, is essential for cellular differentiation in Dictyostelium discoideum. In the absence of nosA, development is blocked, resulting in a developmental arrest at the tight-aggregate stage, when cells differentiate into two precursor cell types, prespore and prestalk cells. Development is restored when a second gene, encoding the ubiquitin-like protein SonA, is inactivated in nosA-mutant cells. SonA has homology over its entire length to Dsk2 from Saccharomyces cerevisiae, a ubiquitin-like protein that is involved in the assembly of the spindle pole body. Dsk2 and SonA are both stable proteins that do not seem to be subjected to degradation via the ubiquitin pathway. SonA does not become ubiquitinated and the intracellular levels of SonA are not affected by the absence of NosA. The high degree of suppression suggests that SonA rescues most or all of the defects caused by the absence of nosA. We propose that NosA and SonA act in concert to control the activity of a developmental regulator that must be deactivated for cells to cross a developmental boundary. ß
Introduction
Eukaryotic cells synthesize proteins that retain certain signatures of ubiquitin and are known as ubiquitin-like proteins [1] . While ubiquitin is conserved among di¡erent species, ubiquitin-like proteins have diverged widely, with homologies to ubiquitin that range from 20% to 60%. All ubiquitin-like proteins are expressed as fusions with C-terminal extensions. One class contains ubiquitin-like proteins that lack the amino acid determinants to be processed and therefore, these proteins remain as fusion proteins, containing the ubiquitin-like domain as an integral part of a larger protein [1] . Ubiquitin-like domains of such fusions do not become conjugated to target proteins. Members of this class of ubiquitin-like proteins include Parkin, Dsk2, and Rad23. These proteins have been implicated in a variety of biological processes, such as a familial form of juvenile Parkinson's disease, chromosome segregation, and DNA repair [2^6] . Yet another ubiquitin-like protein, UBF1, acts as a virulence factor of Leishmania major (S.M. Beverley, unpublished data).
But what is the function of these ubiquitin-like domains? Ubiquitin-like domains could act as primary degradation signals that become ubiquitinated to target itself and the rest of the protein to the proteasome for degradation. This mechanism has been inferred from the discovery of the ubiquitinfusion degradation (UFD) pathway, in which model fusions of ubiquitin and L-galactosidase are degraded in such a manner [7] . That such a mechanism may apply to ubiquitin-like proteins is supported by the fact that ubiquitin can substitute for the ubiquitinlike domain of Rad23 [5] . The ubiquitin-like domain of Rad23 binds the proteasomal subunits cim1 and cim5 and it is this interaction that regulates ubiquitin-mediated degradation of Rad23 [6] . In vitro studies on human Rad23 suggest that the ubiquitin-like domain becomes ubiquitinated by the E3 ubiquitin ligase E6AP in conjunction with the E2 conjugating enzymes UbcH7 and UbcH8 [8] . Whether ubiquitination of Rad23 is required for its degradation is not known.
Another model that has been proposed for ubiquitin-like domains is that they could also act as intramolecular chaperones for the C-terminal extensions, as does ubiquitin. Expression of just the C-terminal extension of the ubiquitin-fusion protein UBI3 does not complement a null-mutation of the wild-type gene, unless provided in multiple copies [9] . A similar role could be assigned to the ubiquitin-like proteins, which are also fused to a tail. The fact that the ubiquitin-like domain cannot be removed might re£ect the need for multiple folding/unfolding, which requires the permanent presence of a chaperone.
Here, we report the identi¢cation of a novel ubiquitin-like protein, which we named SonA, from the cellular slime mold Dictyostelium discoideum. A mutant allele of sonA restores development of a Dictyostelium mutant that is a¡ected in the potential ubiquitination factor NosA. The NosA gene was previously identi¢ed in our laboratory by employing a genetic screen to identify genes that are essential for development of D. discoideum. Disruption of nosA results in a developmental arrest at the tightaggregate stage, when cells di¡erentiate into two precursor cell types, prespore and prestalk cells. Several proteins are stabilized in the nosA mutant, suggesting that the role of NosA during development is to remove a speci¢c set of proteins to ensure developmental progression [10] . The developmental defect is overcome when a mutant allele of sonA is introduced into nosA mutant cells. The isolation of sonA establishes a genetic interaction between ubiquitin-like proteins and NosA-dependent proteolysis.
The NosA homolog in Saccharomyces cerevisiae, UFD2, was identi¢ed by its ability to recognize ubiquitin-fusion proteins as substrates [7] . The similarity of SonA and these arti¢cial substrates led us to ask whether NosA targets the ubiquitin-like domain of SonA. SonA does not become ubiquitinated and the intracellular levels of SonA are not a¡ected by the absence of NosA. We propose that NosA and SonA act in concert to control the activity of a regulator that must be deactivated for cells to develop.
Materials and methods

Strains
All mutants were created in a variant of Ax3 called DH1, which is a uracil auxotroph [11] . The original nosA-mutant strain R7 was derived from DH1 by disruption of the nosA locus using pJB1 as described in [10] . The plasmid pR7-Bcl, containing pJB1 and nosA-£anking regions, was recovered from the mutant R7, and reintroduced into DH1 to yield the retransformant F11. Strain F11 was used for the suppressor analysis.
Suppressor analysis
In order to isolate second-site mutations that restore normal development in the absence of nosA, the nosA mutant F11 was transformed by REMI with the BamHI-cut plasmid pBSR3. The plasmid pBSR3 contains the gene conferring stable blasticidin resistance upon integration of the plasmid into an BamHI or DpnII site in the genome [12] . For this, 10 transformation reactions were prepared as follows: 8.5 ml of 10 7 cells/ml electroporation bu¡er [10 mM sodium/potassium phosphate, 50 mM sucrose, pH 6.1] were mixed with 260 Wg pBsR-3 and 260 U DpnII. Aliquots (0.8 ml) were transferred to cooled 0.4-cm electroporation cuvettes and electroporation was carried out as described [13] . After 3 weeks of selection in HL5 medium [14] supple-mented with 5 Wg/ml blasticidin, resistant transformants were allowed to form plaques on lawns of Klebsiella aerogenes. After 4 days, plates were inspected for fruiting bodies. Spores from these fruiting bodies were collected and treated with 0.2% Triton X-100 for 30 min. Detergent-resistant spores were plated on SM plates with K. aerogenes [14] . Fruiting bodies derived from this plating underwent a second round of detergent treatment. Axenic cultures were derived from clonal populations for each suppressor, which were stored at 380³C. To determine which clones were independent, Southern blots with the radiolabeled BglIII/XhoI-fragment of pUCBsrvBam on NdeI-and BclI-restricted genomic DNA of each strain was carried out [12] . From this, ten independent suppressors were isolated. SonA suppressor strain 3-3 was analyzed in this study.
Northern and Southern blots
DNA and RNA blotting techniques were done as previously described [15] , except that Nytran membranes (Schleicher and Schuell) were used to blot RNA. A probe speci¢c to sonA was prepared by ampli¢cation of a fragment (0.22 kb) from the sonA-cDNA using the primers son1-E (5P-GATGTT-GATGTCGAGTTAG-3P) and son1-D (5P-GGTAC-TTGTTGTTCAACTGG-3P). This polymerase chain reaction (PCR) product was puri¢ed on a low-melting-temperature agarose gel and labeled by random priming [16] .
Immunoprecipitation and Western blots
Protein blotting techniques were performed as described previously [10] . Immunoprecipitation of FLAG-tagged SonA was carried out as described [17] . FLAG(M2) (3.3 Wg) from Sigma was used for each immunoprecipitation.
Pulse-chase analysis
Cells from mid-log cultures were collected by centrifugation (1500Ug; 4 min). Cells were washed once with fresh HL5 and resuspended in pulse-medium (HL5 supplemented with 20 Wg/ml uracil, 0.2% fetal bovine serum (HyClone), and 0.75 mCi/ml Trans 35 SLabel with a speci¢c activity of 1.2 mCi/mmol (ICN)) at a concentration of 10 7 cells/ml. Cells were shaken at 150 rpm at 22³C for 2 h and pelleted. Cells were washed twice with chase medium (HL5 containing 20 Wg/ml uracil, 0.2% fetal bovine serum, 20 mM methionine, and 20 mM cysteine) and resuspended in chase medium at a concentration of 1U10 7 cells/ml. Cells were returned to the shaker and samples of 1U10 7 cells were taken at the indicated times. Cells were pelleted by centrifugation (14 000Ug, 5 s), washed with SorC (16.7 mM Na 2 H/KH 2 PO 4 , 50 WM CaCl 2 , pH 6.0) and lysed in 1 ml TENT (50 mM Tris^HCl (pH 8.0), 2 mM EDTA, 150 mM NaCl, 1% Triton X-100) containing protease inhibitors. Samples were snap-frozen in dryice and stored at 320³C until use for immunoprecipitations as described above. Incorporation of radiolabeled [
35 S]methionine and [ 35 S]cysteine was determined by protein precipitation with trichloroacetic acid (TCA) as described [18] . About 1.2^1.7U10 7 cpm were detected in the insoluble protein fraction derived from 10 7 cells.
Results
Isolation of the sonA-1 allele as a suppressor of nosA
We previously isolated the NosA gene in a genetic screen to identify genes that are essential for cellular di¡erentiation in D. discoideum [13] . NosA is a potential ubiquitination factor that is homologous to UFD2 from S. cerevisiae [19] . The disruption of nosA causes a developmental arrest of D. discoideum at the tight aggregation stage [10] . We suggested that NosA is required for the degradation of negative regulators of the spore cell lineage that need to be removed in order for cells to continue development. Candidates for such regulators are three proteins that accumulate as ubiquitin conjugates in nosA-mutant cells [10] . We designed a genetic suppressor screen to identify genes encoding substrates and interacting partners of NosA. By de¢nition, such suppressors would allow nosA-de¢cient cells to complete development and to form spores. This approach provides the means for a selection: spores can be se-lected by detergent treatment which kills non-encapsulated cells, but leaves spores intact. NosA-mutant cells were mutagenized to introduce second-site mutations that rescue the developmental defect, leading to the formation of fruiting bodies with viable spores. About 8U10 8 nosA-mutant cells were transformed in 100 independent REMI (restriction-endonuclease-mediated-integration) mutagenesis reactions with the restriction enzyme DpnII and the BamHIrestricted plasmid, pBSR3. This screen yielded about 84 000 transformants. A total of 24 000 transformants was examined individually as plaques growing on bacterial lawns of K. aerogenes. Thirty-one colonies produced fruiting bodies with opaque sorocarps, indicating the presence of spores. Southern blot analysis with various enzymes showed that the 31 suppressors produced 10 di¡erent restriction enzyme mapping patterns. The assumption that those ten transformants were a¡ected in di¡erent genes was con¢rmed when the regions £anking the insertion sites were sequenced. These transformants were named Son for suppressors of nosA. The suppressors can be divided into two classes. One class contains mutant alleles of genes that encode proteins related to the ubiquitin system or proteolysis, including the ubiquitin-like protein SonA, and a putative AAAtype protease (SonD). The other class of suppressors contain novel genes that may function as bypass suppressors, or encode novel components of the ubiquitination system.
The mutant allele of sonA restores development of a nosA mutant
Suppression of the nosA mutation was e¤cient, as shown in Fig. 1 . NosA-mutant cells aggregate and form mounds but do not proceed with development ( Fig. 1, middle panel) . A second-site mutation in the sonA gene releases the arrest and allows cells to form fruiting bodies (Fig. 1, left panel) that are indistinguishable from those formed by wild-type cells (Fig.  1, right panel) . Such e¤cient suppression is true for all 10 independent suppressors that emerged from this screen. The creation of the same sonA-1 mutant allele in a wild-type background did not produce any obvious phenotype (data not shown). This result indicates that sonA is not essential for growth or development, which is also true for the homologs dsk2 and dph1 in S. cerevisiae, and Schizosaccharomyces pombe, respectively [2, 20] .
Creation of sonA-1/nosA double mutants by homologous recombination
To test whether the sonA-1 mutant allele is responsible for suppressing the developmental arrest of the nosA mutant, we created mutants by homologous recombination. We recovered a DNA fragment from the original nosA/sonA-1 mutant, which contains pBSR3 and the £anking regions of sonA-1. This DNA fragment was introduced into the nosA mutant to recreate the nosA/sonA-1 suppressor strain. As shown in Fig. 2A , the genomic DNA from these transformants was restricted with BclI and was studied by Southern blot analysis using a speci¢c probe for the plasmid pBSR3. A 7.5 kb fragment was identi¢ed in transformants ( Fig. 2A , lanes 2^5) with suppressed phenotype that matched the size of the fragment derived from the original nosA/ sonA-1 suppressors (lane 1). Transformants with a non-suppressed phenotype had the plasmid inserted at random sites in the genome (Fig. 2A, lanes 7^11) . The insertion of pBSR3 into the sonA locus was con¢rmed by PCR analysis (Fig. 2B) . Transformants with a suppressed phenotype carried the sonA-1 mutant allele (Fig. 2B, lanes 2^5 ), while transformants with a non-suppressed phenotype had an intact sonA locus (Fig. 2B, lanes 7^11 ). This correlation between the site of integration and suppression indicates that it is the mutation of sonA that suppresses the e¡ect of the nosA mutation.
The sonA-1 mutant allele produces a truncated transcript
The insertion of the selectable plasmid pBSR3 into codon 158 of sonA allows nosA-mutant cells to overcome the developmental arrest and to complete development. To determine the nature of this insertional mutation, we studied the expression of nosA in normal and suppressed nosA-mutant cells. As shown in Fig. 2C , the insertion of pBSR3 causes the expression of a truncated transcript of 1.0 kb, compared to the transcript size of 2.1 kb found in the parental strain. This transcript may be translated as a truncated version of SonA. If this is the case, truncated SonA would consist mainly of the ubiquitin-like domain, because pBSR3 inserted downstream from the sonA region that encodes the ubiquitin-like domain. Expression is low during growth and early aggregation, and peaks during later aggregation and mound formation (8^12 h of development). Later in develop- Fig. 2 . Insertional mutation of sonA by homologous recombination rescues development and gives rise to a truncated sonA transcript. (A) nosA-mutant cells were transformed with the rescued plasmid containing the £anking regions of sonA. Development of nine transformants was observed and divided into two classes: transformants with suppressed wild-type phenotype (lanes 2^5) and transformants with a nosA phenotype (lanes 7^11). Genomic DNA was isolated from these transformants and analyzed on Southern blots using a probe speci¢c to the blasticidin resistance marker, and PCR to determine which transformants had the plasmid inserted into the sonA gene. One Wg of genomic DNA was digested with BclI (lane 1, the original suppressor 3-3; lanes 2^11, transformants). The DNA was size-fractionated on 1% agarose gels and transferred to nylon membranes. The integration site of the plasmid was determined by hybridization with a probe generated from the gene conferring blasticidin resistance. (B) Genomic DNA was subjected to PCR with a set of three primers that would amplify a PCR product of 640 bp from intact sonA and a PCR product of 875 bp from mutated sonA*. (C) Five Wg of total RNA from growing amoebae of wild-type (DH1), nosA-mutant (F11), and nosA/sonA-1 doublemutant (F10-1) was size-fractionated on a 1% agarose gel, transferred to nitrocellulose, and hybridized to a probe corresponding to sonA. The sonA transcripts are indicated by arrows. Equal loading was con¢rmed by ethidium bromide staining of the ribosomal bands (not shown). ment, the transcript level decreases to a plateau that corresponds to the level observed during growth. The insertional mutation does not interfere with the expression pattern of sonA (data not shown).
The suppressor SonA codes for a ubiquitin-like protein
The full-length cDNA for sonA was obtained by screening a lambda-ZAP cDNA library. Analysis of this cDNA clone indicates that SonA has an open reading frame of 1569 nucleotides, which codes for a protein with a calculated mass of 56.7 kDa. SonA contains a 77-residue-long ubiquitin-like domain fused to a C-terminal extension of 446 amino acids (Fig. 3) . SonA lacks the amino acid determinants to be cleaved downstream of the ubiquitin-like domain, and therefore belongs to a family of stable ubiquitinlike proteins. Such fusions are not cleaved, and do not become conjugated to other proteins [1] . SonA has homology over its entire length to Dsk2 from S. cerevisiae (Fig. 4) . Dsk2 is involved in spindle pole body (SPB) formation (centrosomes in vertebrates) [2] . Dsk2 is a stable nuclear protein that, when mutated, can complement the de¢ciency to duplicate spindle bodies caused by the absence of the structural SPB component kar1. The mutant allele contains a point mutation that results in a His69Tyr substitution. Overexpression of wild-type Dsk2 or its C-terminal extension without the ubiquitin-like domain does not complement the kar1 mutation. These data demonstrate the vital role of the ubiquitin-like domain for the function of Dsk2. The Dsk2 homolog of S. pombe, Dph1, has a function similar to Dsk2, and its overexpression causes a cell cycle arrest at metaphase [20] .
BLAST homology searches [21] with the SonA sequence established homology to other proteins with ubiquitin-like domains that are similar to ubiquitin. SonA carries a conserved sequence motif at the Cterminus, known as the UBA domain (ubiquitin-associated domain). We identi¢ed the UBA domain of SonA by searching the Prosite database (version 15) [22, 23] . The UBA domain is included in the Prosite database under the accession number PS50030. The UBA domain has an estimated length of 55 amino acids, based on proteins with multiple copies arranged as tandem arrays. The conserved region of the UBA domain is about 45 residues long and is believed to form an K-helix [24] . The UBA domain has been shown to bind ubiquitin non-covalently. In the case of the cellular protein p62, deletion of the UBA domain abolishes the capacity to bind ubiquitin [25] . The UBA domain can be found in all known stable ubiquitin-like proteins, a variety of E2-conjugating enzymes, E3-ligating enzymes, and ubiquitin carboxy terminal hydrolases (for review see [24] ).
3.6. Intracellular levels of SonA do not depend on the activity of the proteasome or NosA
The isolation of sonA-1 establishes a genetic interaction between a ubiquitin-like protein and NosA. The arti¢cial substrates used by Varshavsky and coworkers to identify the NosA homolog UFD2 were fusion proteins with ubiquitin fused to L-galactosidase [7] . SonA shares features with these ubiquitin-L-galactosidase fusions: SonA is expressed as a fusion protein with a domain at its N-terminus that is 61% similar to ubiquitin. The homology between the ubiquitin^L-galactosidase fusions and SonA raised the question whether the NosA/UFD2 pathway acts on ubiquitin-like domains rather than on ubiquitin. UFD2 is a ubiquitination factor that is required for extending ubiquitin chains on target proteins [19] . The sequence homology between UFD2 and NosA suggests that NosA has a similar role in Dictyostelium. If the role of NosA is to assemble multi-ubiquitin chains onto SonA to target SonA to the proteasome for degradation, we should detect an increase in SonA concentrations when the proteasome is blocked. A similar e¡ect would be expected in the absence of NosA, because SonA would be insu¤ciently ubiquitinated and therefore not recognized by the proteasome. We subjected growing wildtype and nosA-mutant cells that express SonA-FLAG to the cell-permeable proteasome inhibitor MG132 [26] and monitored the levels of SonA over a period of 6 h (Fig. 5A) . We observed that both wild-type and nosA-mutant cells respond to the MG132 treatment: ubiquitin conjugates accumulate when the drug is administered (Fig. 5A) . The accumulation of ubiquitin-conjugates is an indication that the proteosome is inhibited. In contrast, the concentrations of SonA are not a¡ected by the presence of the proteasome inhibitor MG132 or the absence of NosA. The levels of SonA were also not a¡ected in similar experiments, in which we monitored the turnover of SonA in pulse-chased nosA-mutant and wildtype cells, in the presence or absence of MG132 (data not shown). These ¢ndings show that the intracellular levels of SonA are not controlled by ubiquitinmediated proteolysis involving the activity of NosA. 7 cells/ ml. Cells were washed with cold medium (HL5) and chased for up to 240 min at a concentration of 1U10 7 cells/ml. Aliquots of 10 7 cells were removed at the indicated times. Labeled SonA-FLAG was precipitated with KFLAG-M2, size-fractionated on a 12.5% SDS^polyacrylamide gel, and detected by phosphor imaging.
To determine the half-life of SonA and to test whether SonA becomes ubiquitinated, wild-type cells and nosA-mutant cells were labeled with [ 35 S]methionine for 120 min and chased for 240 min (Fig. 5B) . SonA is present at about the same levels in wild-type and nosA-mutant cells, and there is no appearance of ubiquitinated intermediates in either cell line. A subtle decrease in SonA concentrations could be observed between the 120-min and 240-min time point. We can, therefore estimate a half-life for SonA as 4 h or greater. This slow decrease in SonA levels is not due to continued incorporation of [
35 S]methionine during the chase period, which would counteract the degradation of SonA by newly synthesized labeled SonA. We monitored the incorporation of [
35 S]methionine during the pulse and chase periods and found that no signi¢cant amount of [ 35 S]methionine was incorporated during the chase ( 6 5%). We conclude that SonA is a stable protein that is not subjected to rapid degradation by the ubiquitin system.
Discussion
The results presented here establish a genetic interaction between the ubiquitin system, a ubiquitin-like protein, and development. We previously identi¢ed the NosA gene, which encodes a potential ubiquitination factor [10, 19] . NosA is homologous to UFD2 from S. cerevisiae, which binds ubiquitinated model substrates and catalyzes the elongation of multiubiquitin chains [19] . The NosA homolog UFD2 from S. cerevisiae was isolated as a result of its ability to degrade model substrates that contain a ubiquitin domain [7] . Disruption of nosA results in a developmental arrest at the tight-aggregation stage, when cells start to di¡erentiate into two precursor cell types, prespore and prestalk cells. The developmental phenotype of nosA-mutant cells may be due to the failure to remove these proteins, which could act as negative regulators of cellular di¡erentiation.
Ubiquitin-like domains have also been shown to function as sites of ubiquitination that target the protein to the proteasome for degradation [6] . The homology between these arti¢cial substrates and SonA raised the question whether a similar mechanism applies to SonA, in which the ubiquitin-like domain of SonA becomes ubiquitinated by NosA. If this were true, NosA-dependent degradation of SonA would be required for cells to proceed with development. We did not ¢nd any evidence that this is the case: the intracellular levels of SonA in vivo are not in£uenced by blocking ubiquitin-mediated proteolysis or by removing NosA from cells. The mechanism of suppression must therefore be different from simply controlling the intracellular levels of SonA.
As shown in Fig. 1 , suppression of the nosA mutation is very e¤cient. NosA-mutant cells that carry a sonA-1 mutant allele complete development, which is indistinguishable from wild-type development. This e¤cient suppression suggests to us that SonA rescues most or all of the defects caused by the absence of nosA. We speculate that SonA is an antagonist of NosA, and acts on the same substrate. A model that is consistent with the presented results is shown in Fig. 6 . The observed suppression of the nosA mutation may be accomplished by deactivating a developmental regulator that accumulates in nosA cells and which prevents developmental progression. Candidates for such regulators are three proteins that accumulate as ubiquitin-conjugates in nosA-mutant cells [10] . SonA contains a ubiquitin-like domain and a UBA-domain, both of which have the capacity to bind other proteins [6, 27] . If SonA binds the putative developmental regulator through one of these domains as shown in Fig. 6 , this developmental regulator may become activated upon binding. We propose that the activated regulator acts as an inhibitor of cellular di¡erentiation (Fig. 6) . The activated developmental regulator would need to be removed from cells, so that the organism can proceed past the tight aggregation stage of development. In this model, the removal of the developmental regulator does not take place in nosA-mutant cells, because NosA is not present to target the complex for degradation. The lack of ubiquitination results in the accumulation of activated regulator, which causes a developmental arrest. The introduction of the sonA-1 mutant allele into these nosA cells rescues development. The mutant form of SonA may not have the capacity to activate the developmental regulator, which leaves the developmental regulator in the deactivated form. Due to the absence of nosA in these cells, the developmental regulator would accumulate in its deactivated from, which would not interfere with the cell's capacity to complete development.
Elucidating the molecular basis of the interaction between SonA and NosA may help to understand the biology of ubiquitin-like proteins, including those like parkin that are involved in disease. The isolation of a mutant allele of sonA as a genetic suppressor of NosA links SonA to regulated proteolysis and to development. The elegant genetics and biochemistry of Dictyostelium puts us in a position to understand the role of the ubiquitin-like protein SonA during cellular di¡erentiation.
